Breaking News

Ascendia Pharmaceuticals Poised for Expansion

CDMO secures growth equity investment from Signet Healthcare Partners.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ascendia Pharmaceuticals, a specialty contract development and manufacturing organization (CDMO) dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical stage drug candidates, and marketed drug products, has received an investment made by Signet Healthcare Partners, a New York-based growth equity firm specializing in healthcare investments. The proceeds will be used to fund Ascendia’s facility expansion to support the growing demand in the sector.   Founded in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters